EURETINA 2025 at a glance

Looking ahead to EURETINA 2025, LucidQuest outlines key developments in retinal science, imaging innovation, treatment advances, and AI-enabled diagnostics.

📅 Build your schedule around the topics that interest you.

📥 Download the EURETINA 2025_Preview_by_LucidQuest

Dive deeper

Key Topics From EURETINA 2025 Scientific Presentations

Geographic Atrophy

  • Trials: OAKS/DERBY/GALE/GATHER1/2; pipelines: ANX007, GAL-101, VERDANT C3, VOY-101, OCU410; real-world baselines: MACUSTAR, INTERCEPT-AMD. 🔬

nAMD / PCV

  • Faricimab vs aflibercept 8 mg across SPECTRUM, SALWEEN, FAR WEST, FARWIDE-nAMD, TRUCKEE, AVONELLE-X: durability, fluid control, switching. 💉

DR / DME

  • PHOTON extension; YOSEMITE/RHINE biomarkers; ELEVATUM equity; real-world aflibercept 8 mg (FARWIDE-DME/TAHOE); pipelines: EYP-1901, OTX-TKI, Restoret, 4D-150. 📊

Surgical Retina

  • BRAVE training; 1,2-SIT injections; tele-screening; YAG floater trials; biosimilars (Tyalia/Oceva); endophthalmitis trends; DIMS outcomes. 🛠️

Inherited Retinal Disease

  • XLRP (SKYLINE/DAWN), OCU400, AAVB-081, PRPF31 (VP-001), RdCVF, MCO-010, voretigene outcomes—endpoints, durability, paired-eye designs. 🧬

Uveitis & Tumors

  • Long-term adalimumab; dexamethasone vs fluocinolone for uveitic edema; VRL/choroidal infiltration radiotherapy; OCT nevus vascularity. 🧯

RVO

  • QUASAR aflibercept 8 mg; HERMES perfusion; TenCRAOS thrombolysis; BALATON/COMINO link early leakage resolution to extended intervals. 🩸

AMD Imaging

  • RPD/HRF signals; OCTA activity metrics (ACTOR/COCTAEYL); PINNACLE microperimetry; eye-tracking; drusenoid evolution analytics. 🖥️

Pachychoroid / CSCR / High Myopia

  • Difluprednate vs eplerenone; brolucizumab in chronic CSCR (no CNV); SS-OCTA PNV metrics; myopic CNV cohorts and 36-month DIMS data. 🌗

Artificial Intelligence and MachineLearning at EURETINA 2025

AI in AMD/GA

  • OCT classification & reproducible GA quantification for standardized endpoints. 🤖

AI in DR/DME

  •  At-scale screening (EyeArt) and response prediction; smartphone tele-screening. 📲

AI in Multimodal Imaging

  •  Fusion of OCT/OCTA/UWF to surface new vascular/RPE biomarkers. 🧩

AI in Surgical Practice

  • Outcome prediction for ERM vitrectomy and surgery planning. 🛠️

AI in DigitalEndpoints and RWE

  •  AI-defined endpoints and automated registry analytics for durability/adherence. ✅

AI for Personalized Therapy

  • Matching imaging phenotypes to faricimab/aflibercept/gene-therapy choices; cytokine and extra-ocular risk signatures. 🎯

📅 Build your schedule around the topics that interest you.

📥 Download the EURETINA 2025_Preview_by_LucidQuest

Contact us for end-to-end conference coverage.

Privacy Preference Center